scholarly article | Q13442814 |
P2093 | author name string | Liu F | |
Rosen N | |||
Tavorath R | |||
Srethapakdi M | |||
P433 | issue | 14 | |
P921 | main subject | retinoblastoma | Q500695 |
P304 | page(s) | 3940-3946 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest | |
P478 | volume | 60 |
Q37199458 | 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1. |
Q40762284 | A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts |
Q33784450 | Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis |
Q34589866 | Activity of the heat shock protein 90 inhibitor ganetespib in melanoma |
Q35564020 | Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. |
Q34616517 | Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers |
Q34335802 | Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor. |
Q40396363 | Cdc28 provides a molecular link between Hsp90, morphogenesis, and cell cycle progression in Candida albicans |
Q35158114 | Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication |
Q37307182 | Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer |
Q41470003 | Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling |
Q33789416 | Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET Receptor |
Q37728631 | HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. |
Q33864144 | HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way |
Q34268075 | Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. |
Q28477348 | High-content, high-throughput analysis of cell cycle perturbations induced by the HSP90 inhibitor XL888 |
Q35823157 | Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs |
Q28474354 | Induction of premature senescence by hsp90 inhibition in small cell lung cancer |
Q39030722 | Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation |
Q64056947 | Leishmania donovani 90 kD Heat Shock Protein - Impact of Phosphosites on Parasite Fitness, Infectivity and Casein Kinase Affinity |
Q42770281 | Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX. |
Q34678359 | New drugs in gynecologic cancer |
Q33713035 | Regulation of survivin function by Hsp90 |
Q35469447 | SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers |
Q37463739 | Targeting HSP90 for cancer therapy |
Q27023406 | Targeting Hsp90 in urothelial carcinoma |
Q35469548 | The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells |
Q35818450 | The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells |
Q42082409 | The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors |
Q64998413 | [The molecular pathogenesis of small cell lung cancer]. |
Search more.